Douglas B. Stairs

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

Adam J. Bass, Hideo Watanabe, Craig H. Mermel et al. · Nature Genetics · 2009 · 944 citations · Full text

Tumor Biology, Oncogenic Agent, Medicine +9

Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis

Christopher J. Sarkisian, Blaine A. Keister, Douglas B. Stairs et al. · Nature Cell Biology · 2007 · 486 citations

Breast Oncology, Oncology, Oncogenic Agent +10

Deletion of p120-Catenin Results in a Tumor Microenvironment with Inflammation and Cancer that Establishes It as a Tumor Suppressor Gene

Douglas B. Stairs, Lauren J. Bayne, Ben Rhoades et al. · Cancer Cell · 2011 · 188 citations · Full text

Tumor Biology, P120-catenin Results, Oncology +8

Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors

Shinya Ohashi, Mitsuteru Natsuizaka, Gabrielle S. Wong et al. · Cancer Research · 2010 · 173 citations · Full text

Esophageal Cancer, Pathology, Cell Proliferation +20

The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation

Takaomi Okawa, Carmen Z. Michaylira, Jiří Kalabis et al. · Genes & Development · 2007 · 173 citations · Full text

Esophageal Cancer, P53 Mutation, Pathology +14